Provided by Tiger Trade Technology Pte. Ltd.

Carlisle

360.82
-6.8600-1.87%
Volume:174.47K
Turnover:63.58M
Market Cap:14.33B
PE:20.74
High:372.74
Open:366.56
Low:359.65
Close:367.68
52wk High:432.91
52wk Low:293.43
Shares:39.71M
Float Shares:39.20M
Volume Ratio:0.59
T/O Rate:0.45%
Dividend:4.40
Dividend Rate:1.22%
EPS(TTM):17.39
EPS(LYR):17.12
ROE:39.18%
ROA:10.81%
PB:8.86
PE(LYR):21.08

Loading ...

U.S. Earnings Preview: After Market Close April 23

Dow Jones
·
Apr 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 22

CSL Shares Hit Nearly 9-Year Low as US Drops Flu Vaccine Mandate

MT Newswires Live
·
Apr 22

CSL (CMXHF) Gets a Hold from Ord Minnett

TIPRANKS
·
Apr 22

PolyNovo names CSL veteran Marthe D’Ombrain as Chief Scientific Officer to drive next-phase growth

TIPRANKS
·
Apr 22

Carlisle Cos Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Apr 21

Oppenheimer Adjusts Price Target on Carlisle to $420 From $435, Maintains Outperform Rating

MT Newswires Live
·
Apr 20

How Investors Are Reacting To Carlisle Companies (CSL) As Analysts Trim Earnings Expectations

Simply Wall St.
·
Apr 20

Carlisle Companies Inc. : Oppenheimer Cuts Target Price to $420 From $435

THOMSON REUTERS
·
Apr 20

U.S. RESEARCH ROUNDUP-Carpenter Technology, IBM, Ulta Beauty

Reuters
·
Apr 20

CSL Records Lapse of Conditional Rights in Minor Capital Adjustment

TIPRANKS
·
Apr 20

Earning Preview: Carlisle Q1 revenue is expected to decrease by 2.41%, and institutional views are limited but lean neutral

Earnings Agent
·
Apr 16

CSL Bulls See Valuation Support Despite Challenges -- Market Talk

Dow Jones
·
Apr 16

Carlisle Cos Is Maintained at Outperform by Baird

Dow Jones
·
Apr 15

Ord Minnett Sticks to Its Hold Rating for CSL (CMXHF)

TIPRANKS
·
Apr 13

CSL Bull Downbeat About Current Industry Growth of Immunoglobulin, Albumin -- Market Talk

Dow Jones
·
Apr 13

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CSL (OtherCMXHF), Fortrea Holdings Inc. (FTRE) and Olympus (OtherOCPNF)

TIPRANKS
·
Apr 12

Is It Too Late To Consider Carlisle Companies (CSL) After Recent Mixed Price Momentum?

Simply Wall St.
·
Apr 10

How Investors May Respond To CSL (ASX:CSL) Downplaying Impact Of New US Drug Tariffs

Simply Wall St.
·
Apr 10